Robert Ho
2020 - Aquinox Pharmaceuticals
In 2020, Robert Ho earned a total compensation of $2.7M as Former Chief Financial Officer at Aquinox Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $119,210 |
|---|---|
| Salary | $280,000 |
| Stock Awards | $2,255,062 |
| Total | $2,654,272 |
Ho received $2.3M in stock awards, accounting for 85% of the total pay in 2020.
Ho also received $119.2K in non-equity incentive plan and $280K in salary.
Rankings
In 2020, Robert Ho's compensation ranked 4,324th out of 13,090 executives tracked by ExecPay. In other words, Ho earned more than 67.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,324 out of 13,090 | 67th |
Division Manufacturing | 1,755 out of 5,618 | 69th |
Major group Chemicals And Allied Products | 686 out of 2,251 | 70th |
Industry group Drugs | 587 out of 1,951 | 70th |
Industry Pharmaceutical Preparations | 447 out of 1,456 | 69th |
Source: SEC filing on March 31, 2022.
Ho's colleagues
We found one more compensation record of an executive who worked with Robert Ho at Aquinox Pharmaceuticals in 2020.
2020
Jonathan Drachman
Aquinox Pharmaceuticals